The neuropathological spectrum of neurodegenerative tauopathies

IUBMB Life

Volumn 55, Issue 6, 2003, Pages 299-305

  Tolnay, Markus ^a,b   Probst, Alphonse ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Alzheimer's disease; Frontotemporal dementia; FTDP 17; Tau proteins; Tauopathy

Indexed keywords

TAU PROTEIN;

ALZHEIMER DISEASE; BIOCHEMISTRY; CHEMICAL STRUCTURE; CHROMOSOME 17; CORTICOBASAL DEGENERATION; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HUMAN; MORPHOLOGY; NERVE DEGENERATION; NEUROPATHOLOGY; NIEMANN PICK DISEASE; PARKINSONISM; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN DEFECT; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; TAUOPATHY;

ALZHEIMER DISEASE; HUMANS; PICK DISEASE OF THE BRAIN; PROTEIN ISOFORMS; TAU PROTEINS; TAUOPATHIES;

EID: 0042027817     PISSN: 15216543     EISSN: None     Source Type: Journal    
DOI: 10.1080/1521654032000114348     Document Type: Review

References (42)

1. Andreadis, A., Brown, W. M., and Kosik, K. S. (1992) Structure and novel exons of the human tau gene. Biochemistry 31, 10626-10633.
2. Buée, L., Bussière, T., Buée-Scherrer, V., Delacourte, A., and Hof, P. R. (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Rev. 33, 95-130.
3. Hardy, J., and Selkoe, D. J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356.
4. Nussbaum, R. L., and Collins, F. S. (2003) Alzheimer's disease and Parkinson's disease. N. Engl. J. Med. 348, 1356-1364.
5. Probst, A., Langui, D., and Ulrich, J. (1991) Alzheimer's disease: a description of the structural lesions. Brain Pathol. 1, 229-239.
6. Tolnay, M., and Probst, A. (1999) Review: tau protein pathology in Alzheimer's disease and related disorders. Neuropathol. Appl. Neurobiol. 25, 171-187.
7. Braak, H., and Braak, E. (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 82, 239-259.
8. Delacourte, A., David, J. P., Sergeant, N., Wattez, A., Vermersch, P., Ghozali, F., Fallet-Bianco, C., Pasquier, F., Lebert, F., Petit, H., et al. (1999) The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology 52, 1158-1165.
9. Delacourte, A., and Buée, L. (2000) Tau pathology: a marker of neurodegenerative disorders. Curr. Opin. Neurol. 13, 371-376.
10. Goedert, M., Spillantini, M. G., Cairns, N. J., and Crowther, R. A. (1992) Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron 8, 159-168.
11. Greenberg, S. G., Davis, P., Schein, J. D., and Binder, L. I. (1992) Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. J. Biol. Chem. 267, 564-569.
12. Lee, V. M.-Y., Goedert, M., and Trojanowski J. Q. (2001) Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24, 121-159.
13. Goedert, M., Jakes, R., Spillantini, M. G., Hasegawa, M., Smith, M. J., and Crowther, R. A. (1996) Sulphated glycosaminoglycans induce assembly of microtubule-associated protein tau into Alzheimer-like filaments. Nature 383, 550-553.
14. Pérez, M., Valpuesta, J. M., Medina, M., Montejo de Garcini, E., and Avila, J. (1996) Polymerization of tau into filaments in the presence of heparin: the minimal sequence required for tau-tau interaction. J. Neurochem. 67, 1183-1190.
15. Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) Frontotemporal lobar degeneration. A consensus on clinical diagnostic criteria. Neurology 51, 1546-1554.
16. Tolnay, M., and Probst, A. (2002) Frontotemporal lobar degeneration - tau as a pied piper? Neurogenetics 4, 63-75.
17. McKhann, G. M., Albert, M. S., Grossman, M., Miller, B., Dickson, D., and Trojanowski, J. Q. (2001) Clinical and pathological diagnosis of frontotemporal dementia. Report of the work group on frontotemporal dementia and Pick's disease. Arch. Neurol. 58, 1803-1809.
18. Dickson, D. W. (1998) Pick's disease: a modern approach. Brain Pathol. 8, 339-354.
19. Litvan, I. (2001) Diagnosis and management of progressive supranuclear palsy. Semin. Neurol. 21, 41-48.
20. Conrad, C., Andreadis, A., Trojanowski, J. Q., Dickson, D. W., Kang, D., Chen, X., Wiederholt, W., Hansen, L., Masliah, E., Thal, L. J., et al. (1997) Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann. Neurol. 41, 277-281.
21. Baker, M., Litvan, I., Houlden, H., Adamson, J., Dickson, D., Perez-Tur, J., Hardy, J., Lynch, T., Bigio, E., and Hutton, M. (1999) Association of an extendend haplotype in the tau gene with progressive supranuclear palsy. Hum. Mol. Genet. 8, 711-715.
22. Grimes, D. A., Lang, A. E., Bergeron, C. B. (1999) Dementia as the most common presentation of cortical-basal ganglionic degeneration. Neurology 53, 1969-1974.
23. Komori, T. (1999) Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease. Brain Pathol. 9, 663-679.
24. Houlden, H., Baker, M., Morris, H. R., MacDonald, N., Pickering-Brown, S., Adamson, J., Lees, A. J., Rossor, M. N., Quinn, N. P., Kertesz, A., et al. (2001) Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology 56, 1702-1706.
25. Braak, H., and Braak, E. (1998) Argyrophilic grain disease: frequency of occurrence in different age categories and neuropathological diagnostic criteria. J. Neural Transm. 105, 801-819.
26. Tolnay, M., Monsch, A. U., and Probst, A. (2001) Argyrophilic grain disease: a frequent dementing disorder in aged patients. Adv. Exp. Med. Biol. 487, 39-58.
27. Togo, T., Sahara, N., Shu-Hui, Y., Cookson, N., Ishizawa, T., Hutton, M., De Silva, R., Lees, A., and Dickson, D. W. (2002) Argyrophilic grain disease is a sporadic 4-repeat tauopathy. J. Neuropathol. Exp. Neurol. 61, 547-556.
28. Tolnay, M., Sergeant, N., Ghestem, A., Chalbot, S., de Vos, R. A. I., Jansen Steur, E. N. H., Probst, A., and Delacourte, A. (2002) Argyrophilic grain disease and Alzheimer's disease are distinguished by their different distribution of tau protein isoforms. Acta Neuropathol. 104, 425-434.
29. Zhukareva, V., Shah, K., Uryu, K., Braak, H., Del Tredici, K., Sundarraj, S., Clark, C., Trojanowski, J. Q., and Lee, V. M.-Y. (2002) Biochemical analysis of tau proteins in argyrophilic grain disease, Alzheimer's disease, and Pick's disease. A comparative study. Am. J. Pathol. 161, 1135-1141.
30. Wilhelmsen, K. C., Lynch, T., Pavlou, E., Higgins, M., and Nygaard, T. G. (1994) Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22. Am. J. Hum. Genet. 55, 1159-1165.
31. Foster, N. L., Wilhelmsem, K., Sima, A. A. F., Johnes, M. Z., D'Amato, C. J., Gilman, S., Spillantini, M. G., Lynch, T., Mayeux, R. P., Gaskell, P.-C., et al. (1997) Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Ann. Neurol. 41, 706-715.
32. Ingram, E. M., and Spillantini, M. G. (2002) Tau gene mutations: dissecting the pathogenesis of FTDP-17. Trends Mol. Med. 8, 555-562.
33. Spillantini, M. G., Bird, T. D., and Ghetti, B. (1998) Frontotemporal dementia and parkinsonism linked to chromosome 17: a new group of tauopathies. Brain Pathol. 8, 387-402.
34. Poorkaj, P., Bird, T. D., Wijsman, E., Nemens, E., Garruto, R. M., Anderson, I., Andreadis, A., Wiederholt, W. C., Raskind, M., and Schellenberg, G. D. (1998) Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann. Neurol. 43, 815-825.
35. Spillantini, M. G., Murell, R. J., Goedert, M., Farlow, M. R., Klug, A., and Ghetti, B. (1998) Mutation in the tau gene for chromosome 17 frontotemporal dementia. Proc. Natl. Acad. Sci. U.S.A. 95, 7737-7741.
36. Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) Association of missense and 5′-splice site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702-705.
37. Zhukareva, V., Vogelsberg-Ragaglia, V., Van Deerlin, V. M. D. Bruce, J., Shuck, T., Grossman, M., Clark, C. M., Arnold, S. E., Masliah, E., Galasko, D., et al. (2001) Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia. Ann. Neurol. 49, 165-175.
38. Zhukareva, V., Sundarraj, S., Mann, D., Sjogren, M., Blenow, K., Clark, C. M., McKeel, D. W., Goate, A., Lippa, C. F., Vonsattel, J.-P., et al. (2003) Selective reduction of soluble tau proteins in sporadic and familial frontotemporal dementias: an international follow-up study. Acta Neuropathol. 105, 469-476.
39. Lendon, C. L., Lynch, T., Norton, J., McKeel, D. W., Busfield, F., Craddock, N., Chakraverty, S., Gopalakrishnan, G., Shears, S. D., Grimmett, W., et al. (1998) Hereditary dysphasic disinhibition dementia. A frontotemporal dementia linked to 17q21-22. Neurology 50, 1546-1555.
40. Götz, J. (2001) Tau and transgenic animal models. Brain Res. Brain Res. Rev. 35, 266-286.
41. Bonini, N. M., and Fortini, M. E. (2003) Human neurodegenerative disease modeling using Drosophila. Annu. Rev. Neurosci. 26, 627-656.
42. Tolnay, M., Spillantini, M. G., Rizzini, C., Eccles, D., Lowe, J., and Ellison, D. (2000) A new case of frontotemporal dementia and parkinsonism resulting from an intron 10 + 3-splice site mutation in the tau gene: clinical and pathological features. Neuropathol. Appl. Neurobiol. 26. 368-378.